{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:27:51Z","timestamp":1788362871337,"version":"build-2803163510"},"reference-count":110,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073385"],"award-info":[{"award-number":["82073385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172706"],"award-info":[{"award-number":["82172706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20DZ2255200"],"award-info":[{"award-number":["20DZ2255200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Commission of Shanghai Municipality","award":["82073385"],"award-info":[{"award-number":["82073385"]}]},{"name":"Science and Technology Commission of Shanghai Municipality","award":["82172706"],"award-info":[{"award-number":["82172706"]}]},{"name":"Science and Technology Commission of Shanghai Municipality","award":["20DZ2255200"],"award-info":[{"award-number":["20DZ2255200"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is an inflammatory skin disease mediated by the immune system and characterized by an inflammatory ring, also known as an epithelial immune microenvironment (EIME). The interaction between the epithelial tissue of the skin and the immune system has a crucial role in the immune cycle of psoriasis. Although the formation of new blood vessels in skin lesions provides energy support for the proliferation of epidermal keratinocytes, the role of angiogenesis in psoriasis has not been extensively studied. Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis that has an important role in the development of psoriasis. VEGFA promotes angiogenesis and directly stimulates epidermal keratinocytes and infiltrating immune cells, thus contributing to the progression of psoriasis. Measuring VEGFA levels to identify angiogenic characteristics in psoriasis patients may be a predictive biomarker for disease severity and response to anti-angiogenic therapy. Clinical data have shown that anti-angiogenic therapy can improve skin lesions in psoriasis patients. Therefore, this study aimed to uncover the underestimated role of blood vessels in psoriasis, explore the relationship between VEGFA and keratinocytes in the EIME, and inspire innovative drug therapies for the treatment of psoriasis.<\/jats:p>","DOI":"10.3390\/ijms25010059","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T03:47:56Z","timestamp":1703044076000},"page":"59","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis"],"prefix":"10.3390","volume":"25","author":[{"given":"Ya","family":"Chen","sequence":"first","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5603-745X","authenticated-orcid":false,"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41423-022-00940-8","article-title":"The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry","volume":"19","author":"Zhou","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2014.08.010","article-title":"Classification of inflammatory skin diseases: A proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity","volume":"76","author":"Dainichi","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Hong, Y.J., and Kim, M. (2021). Angiogenesis in Chronic Inflammatory Skin Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222112035"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jphs.2015.05.008","article-title":"Anti-psoriatic effects of Honokiol through the inhibition of NF-\u03baB and VEGFR-2\/Flk1 in animal model of K14-VEGF transgenic mouse","volume":"128","author":"Wen","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.acthis.2010.07.003","article-title":"Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: An immunohistochemical study","volume":"113","author":"Zhang","year":"2011","journal-title":"Acta Histochem."},{"key":"ref_8","first-page":"461","article-title":"Microvascular changes in relation to inflammation and epidermal hyperplasia in chronic cutaneous lesions of psoriasis vulgaris","volume":"32","year":"2017","journal-title":"Histol. Histopathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/idoj.IDOJ_147_17","article-title":"Expression of Vascular Endothelial Growth Factor and Microvessel Density in Psoriatic Skin Lesions","volume":"9","author":"Rajan","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphys.2019.00238","article-title":"Expression Pattern of Angiogenic Factors in Healthy Heart in Response to Physical Exercise Intensity","volume":"10","author":"Bellafiore","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(19)30952-3","article-title":"Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): A randomised, double-blind, active-comparator-controlled phase 3 trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Andrade, M.M.D.L., Tejada, G.L., Peruzzo, J., and Bonamigo, R.R. (2023). Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab. An. Bras. Dermatol., 30.","DOI":"10.1016\/j.abd.2023.02.003"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.7150\/thno.31144","article-title":"In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1183\/09031936.00165308","article-title":"Anti-angiogenic activity of carebastine: A plausible mechanism affecting airway remodelling","volume":"34","author":"Mangialardi","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5603\/AA.2018.0019","article-title":"The role of VEGF in psoriasis: An update","volume":"24","author":"Gerkowicz","year":"2018","journal-title":"Acta Angiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10456-021-09798-2","article-title":"Angiogenesis: A year in review","volume":"24","author":"Griffioen","year":"2021","journal-title":"Angiogenesis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/idoj.IDOJ_309_17","article-title":"The Dermoscopic Auspitz Sign","volume":"9","author":"Kaliyadan","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","article-title":"Angiogenesis and lymphangiogenesis in inflammatory skin disorders","volume":"73","author":"Varricchi","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjd.20940","article-title":"Antivascular endothelial growth factor-A therapy: A novel personalized treatment approach for psoriasis","volume":"186","author":"Paus","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12625746","article-title":"Angiogenesis in psoriasis: Therapeutic implications","volume":"59","author":"Folkman","year":"1972","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","first-page":"5629","article-title":"A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines","volume":"46","author":"Senger","year":"1986","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI114322","article-title":"Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis","volume":"84","author":"Connolly","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Welsh","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2011.03.018","article-title":"Leukotriene D4 enhances tumor necrosis factor-\u03b1-induced vascular endothelial growth factor production in human monocytes\/macrophages","volume":"55","author":"Haneda","year":"2011","journal-title":"Cytokine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"White, A.L., and Bix, G.J. (2023). VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases. Biomolecules, 13.","DOI":"10.3390\/biom13040702"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13046-020-01594-y","article-title":"The circular RNA 001971\/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41581-020-0260-2","article-title":"Targeting angiogenesis and lymphangiogenesis in kidney disease","volume":"16","author":"Tanabe","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/RLI.0b013e3182174fad","article-title":"Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121\/rGel","volume":"46","author":"Cho","year":"2011","journal-title":"Investig. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1158\/0008-5472.CAN-07-6577","article-title":"Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity","volume":"68","author":"Kawamura","year":"2008","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C241","DOI":"10.1152\/ajpcell.00187.2007","article-title":"VEGF and thrombin induce MKP-1 through distinct signaling pathways: Role for MKP-1 in endothelial cell migration","volume":"294","author":"Kinney","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","unstructured":"Zhang, H. (2008). Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US). Created 1 July 2008; Updated 12 August 2008; 2004\u20132013."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2019.04.040","article-title":"Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN\/PI3K\/Akt signaling pathway","volume":"227","author":"Cheng","year":"2019","journal-title":"Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41392-021-00765-3","article-title":"Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a\/Src","volume":"6","author":"Xiao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/s41467-020-16618-6","article-title":"Pericyte FAK negatively regulates Gas6\/Axl signalling to suppress tumour angiogenesis and tumour growth","volume":"11","author":"Lechertier","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3892\/ijmm.2022.5199","article-title":"Exosomes derived from dental pulp stem cells accelerate cutaneous wound healing by enhancing angiogenesis via the Cdc42\/p38 MAPK pathway","volume":"50","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41419-021-04363-7","article-title":"Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-\u03b2\/Smad2\/3 pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/CIRCULATIONAHA.108.823997","article-title":"G-protein-coupled receptor kinase interacting protein-1 is required for pulmonary vascular development","volume":"119","author":"Pang","year":"2009","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jdermsci.2007.10.003","article-title":"Single nucleotide polymorphisms of VEGF gene and Psoriasis risk","volume":"49","author":"Wang","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/ced.14102","article-title":"Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis","volume":"45","author":"Young","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"eaax5849","DOI":"10.1126\/sciadv.aax5849","article-title":"Epidermal autonomous VEGFA\/Flt1\/Nrp1 functions mediate psoriasis-like disease","volume":"6","author":"Benhadou","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_44","first-page":"47","article-title":"Comparative expression of PEDF and VEGF in human epidermal keratinocytes and dermal fibroblasts: From normal skin to psoriasis","volume":"25","author":"Yan","year":"2018","journal-title":"Discov. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: Armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2014A possible target for novel therapies?","volume":"8","author":"Canavese","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2021.09.042","article-title":"IL-30 ameliorates imiquimod and K14-VEGF induced psoriasis-like disease by inhibiting both innate and adaptive immunity disorders","volume":"579","author":"Liu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.4238\/2014.January.24.14","article-title":"Nerve growth factor regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes via PI3K\/mTOR pathway","volume":"13","author":"Zhang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1570161114666160106151837","article-title":"Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model","volume":"14","author":"Wu","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.0906-6705.2006.00416.x","article-title":"Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis","volume":"15","author":"Barile","year":"2006","journal-title":"Exp. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/dna.2013.2252","article-title":"Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: A meta-analysis","volume":"33","author":"Qi","year":"2014","journal-title":"DNA Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e14727","DOI":"10.1111\/dth.14727","article-title":"Assessment of selected angiogenesis markers in the serum of middle-aged male patients with plaque psoriasis","volume":"34","author":"Socha","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ced\/llac047","article-title":"Cutaneous vascular structure and perfusion in patients with chronic plaque psoriasis","volume":"48","author":"Chaudhry","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/0019-5154.143574","article-title":"Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer","volume":"59","author":"Riar","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"ref_56","unstructured":"Wu, R., Luo, X., Zhang, P., Li, S., Zhao, M., Su, Z., Deng, M., Zhu, Y., Tang, G., and Kuang, Q. (2022). Application of Auranofin in the Preparation of Drugs for the Prevention, Treatment and\/or Alleviation of Psoriasis. (CN202111564985)."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"Rafaels","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: A review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ferrari, D., Casciano, F., Secchiero, P., and Reali, E. (2021). Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179449"},{"key":"ref_61","first-page":"341","article-title":"Overview of psoriasis","volume":"17","author":"Goedkoop","year":"2004","journal-title":"Dermatol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5178","article-title":"Keratin 17 in disease pathogenesis: From cancer to dermatoses","volume":"247","author":"Yang","year":"2019","journal-title":"J. Pathol."},{"key":"ref_63","first-page":"1750","article-title":"Deletion of K1\/K10 does not impair epidermal stratification but affects desmosomal structure and nuclear integrity","volume":"125","author":"Wallace","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.20652","article-title":"The Human Intermediate Filament Database: Comprehensive information on a gene family involved in many human diseases","volume":"29","author":"Szeverenyi","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1073\/pnas.1309576110","article-title":"Keratin 16 regulates innate immunity in response to epidermal barrier breach","volume":"110","author":"Lessard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1172\/JCI84870","article-title":"Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes","volume":"126","author":"Kerns","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/MCB.19.4.3086","article-title":"Modulation of cell proliferation by cytokeratins K10 and K16","volume":"19","author":"Paramio","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2006.02.033","article-title":"Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis","volume":"54","author":"Shen","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.yexcr.2017.09.021","article-title":"Vascular endothelial growth factor driving aberrant keratin expression pattern contributes to the pathogenesis of psoriasis","volume":"360","author":"Jiang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: Good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.12.013","article-title":"VEGFA promotes IL-17A-producing \u03b3\u03b4 T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells","volume":"74","author":"Suzuki","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1600-0625.2005.00356.x","article-title":"Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales","volume":"14","author":"Zhang","year":"2005","journal-title":"Exp. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.2008.08889.x","article-title":"Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis","volume":"160","author":"Henno","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/mmr.2017.6623","article-title":"Effects of interleukin-17 on human retinal vascular endothelial cell capillary tube formation in vitro","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/exd.13461","article-title":"TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin","volume":"27","author":"Patel","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mercurio, L., Failla, C.M., Capriotti, L., Scarponi, C., Facchiano, F., Morelli, M., Rossi, S., Pagnanelli, G., Albanesi, C., and Cavani, A. (2020). Interleukin (IL)-17\/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0222969"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.coi.2018.05.011","article-title":"Dendritic cells in inflammatory angiogenesis and lymphangiogenesis","volume":"53","author":"Bosisio","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/jid.2009.96","article-title":"Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation","volume":"129","author":"Bluth","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-021-01102-5","article-title":"The relationship between expression of PD-L1 and HIF-1\u03b1 in glioma cells under hypoxia","volume":"14","author":"Ding","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Luo, D., Wang, Z., Wu, J., Jiang, C., and Wu, J. (2014). The role of hypoxia inducible factor-1 in hepatocellular carcinoma. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/409272"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e01642","DOI":"10.1016\/j.heliyon.2019.e01642","article-title":"Knockdown of TRAF3IP2 suppresses the expression of VEGFA and the proliferation of keratinocytes and vascular endothelial cells","volume":"5","author":"Song","year":"2019","journal-title":"Heliyon"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/1346-8138.15370","article-title":"miR-205-5p inhibits psoriasis-associated proliferation and angiogenesis: Wnt\/\u03b2-catenin and mitogen-activated protein kinase signaling pathway are involved","volume":"47","author":"Xue","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): A dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/1389450121666200319111710","article-title":"Anti-VEGF Treatment in Corneal Diseases","volume":"21","author":"Giannaccare","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cllc.2020.02.024","article-title":"The Story of Angiogenesis Inhibitors in Non-small-cell Lung Cancer: The Past, Present, and Future","volume":"21","author":"Shukla","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12013-013-9563-2","article-title":"Antiangiogenic effect of methotrexate and PUVA on psoriasis","volume":"67","author":"Shaker","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1097\/MJT.0000000000000330","article-title":"Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis","volume":"23","author":"Chen","year":"2016","journal-title":"Am. J. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/pme-2017-0085","article-title":"The polymorphisms of growth factor genes (VEGFA & EGF) were associated with response to acitretin in psoriasis","volume":"15","author":"Chen","year":"2018","journal-title":"Pers. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1111\/j.1365-2230.2008.02991.x","article-title":"Complete remission of psoriasis following bevacizumab therapy for colon cancer","volume":"34","author":"Akman","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/09546634.2018.1506082","article-title":"The effect of adalimumab on the vasculature in psoriatic skin lesions","volume":"30","author":"Hanssen","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/exd.14836","article-title":"Overexpression and potential roles of midkine via regulation of vascular endothelial growth factor A in psoriasis","volume":"23","author":"Li","year":"2023","journal-title":"Exp. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"175276","DOI":"10.1016\/j.ejphar.2022.175276","article-title":"Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model","volume":"933","author":"Tang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/1570161115666171004123428","article-title":"Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod-induced Psoriatic Mouse Model","volume":"16","author":"Liu","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Tang, K.W., Lin, Z.C., Chen, Y.L., Tzeng, C.C., Fang, J.Y., and Tseng, C.H. (2018). Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103061"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Amagai, R., Takahashi, T., Terui, H., Fujimura, T., Yamasaki, K., Aiba, S., and Asano, Y. (2023). The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010875"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Wang, W., Wang, H. (2019). Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease. Biol. Res., 52.","DOI":"10.1186\/s40659-019-0255-2"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1684\/ejd.2018.3357","article-title":"Eosin treatment for psoriasis reduces skin leukocyte infiltration and secretion of inflammatory chemokines and angiogenic factors","volume":"28","author":"Capriotti","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1159\/000430272","article-title":"Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model","volume":"36","author":"Zhou","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdermsci.2014.03.001","article-title":"Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation","volume":"74","author":"Wen","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"16068","DOI":"10.1038\/s41598-018-34293-y","article-title":"Drug survival of biologics in treating psoriasis: A meta-analysis of real-world evidence","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1208\/s12248-014-9637-0","article-title":"Biological products for the treatment of psoriasis: Therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications","volume":"16","author":"Wang","year":"2014","journal-title":"AAPS J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.det.2018.07.004","article-title":"Biologics and Psoriasis: The Beat Goes On","volume":"37","author":"Kim","year":"2019","journal-title":"Dermatol. Clin."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lopes-Coelho, F., Martins, F., Pereira, S.A., and Serpa, J. (2021). Anti-Angiogenic Therapy: Current Challenges and Future Perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073765"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2017.08.012","article-title":"Bevacizumab-induced hypertension: Clinical presentation and molecular understanding","volume":"182","author":"Li","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102017","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: A review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/59\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:51Z","timestamp":1760132511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25010059"],"URL":"https:\/\/doi.org\/10.3390\/ijms25010059","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]}}}